Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEA for Postoperative Pain in Below Knee Fracture
NCT05317676Phase 2Withdrawn
- Sponsor
- University of California, Irvine
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palmitoylethanolamide in postoperative pain, inflammation, sponsored by University of California, Irvine. Planned start May 2023; status: withdrawn.
02
Drugs
palmitoylethanolamide
03
Conditions
postoperative paininflammation
Beyond the preview
Go deeper on NCT05317676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05317676.